Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Recurrent C. Difficile in Children
NCT01972334Phase 2Completed
- Sponsor
- MemorialCare
- Start
- Oct 2013
- Primary completion
- Jul 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Clostridioides difficile colitis (CDI) comparing FMT Arm with Placebo Arm (2 arms). Primary endpoint: Time of recurrence of an infection at 12 months. Started Oct 2013; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on NCT01972334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972334.